Please check your internet connection and try again.
## Sompraz HP
### Overview
Sompraz HP is a combination product containing pantoprazole, amoxicillin, and clarithromycin, used for the eradication of *Helicobacter pylori* (*H. pylori*). Pantoprazole is a proton pump inhibitor (PPI), amoxicillin is a penicillin-class antibiotic, and clarithromycin is a macrolide antibiotic.
### Primary Indications
* Treatment of *Helicobacter pylori* infection in patients with duodenal or gastric ulcers.
### Adult Dosing
* **Recommended Regimen:** One pantoprazole 40 mg, amoxicillin 1000 mg, and clarithromycin 500 mg delayed-release capsule, taken orally twice daily for 7 to 14 days.
* **Note:** The specific duration of therapy (7 or 14 days) may vary based on local guidelines and patient factors.
### Pediatric Dosing
* Specific pediatric dosing for Sompraz HP is not established. Dosing of individual components should be based on pediatric guidelines.
### Dose Adjustments
* **Renal Impairment:** No dose adjustment is recommended for pantoprazole. Dosing of amoxicillin and clarithromycin may require adjustment in severe renal impairment. Consult individual drug monographs.
* **Hepatic Impairment:** No dose adjustment is recommended for pantoprazole in mild to moderate hepatic impairment. Use with caution in severe hepatic impairment. Dosing of amoxicillin and clarithromycin may require adjustment. Consult individual drug monographs.
### Contraindications
* Hypersensitivity to pantoprazole, amoxicillin, clarithromycin, or any component of the formulation.
* History of allergic reactions to penicillins, cephalosporins, or other beta-lactam antibiotics.
* History of cholestatic jaundice/hepatic dysfunction associated with prior clarithromycin use.
* Electrolyte abnormalities (e.g., hypokalemia, hypomagnesemia) for pantoprazole.
* Concomitant use with certain drugs, such as cisapride, pimozide, and ergot alkaloids, due to clarithromycin.
### Adverse Effects
* **Common:** Diarrhea, nausea, abdominal pain, headache, dysgeusia (altered taste), rash.
* **Serious:** *Clostridioides difficile*-associated diarrhea, Stevens-Johnson syndrome/toxic epidermal necrolysis, anaphylaxis, liver enzyme elevations, QT prolongation (clarithromycin), allergic reactions (amoxicillin).
### Key Drug Interactions
* **Pantoprazole:** May decrease the absorption of drugs that require gastric acidity for absorption (e.g., ketoconazole, itraconazole, digoxin). May increase the absorption of drugs that are sensitive to gastric pH.
* **Amoxicillin:** Can decrease the effectiveness of oral contraceptives. May potentiate the effect of warfarin. Probenecid may increase and prolong amoxicillin blood levels.
* **Clarithromycin:** Strong CYP3A4 inhibitor. Can increase plasma concentrations of drugs metabolized by CYP3A4 (e.g., statins, certain calcium channel blockers, immunosuppressants, anticoagulants like warfarin). Avoid concurrent use with colchicine, cisapride, pimozide, ergotamine, and certain benzodiazepines.
### Monitoring
* Assess for signs and symptoms of *H. pylori* eradication (e.g., resolution of ulcer symptoms). Urea breath test or stool antigen test may be used to confirm eradication.
* Monitor for adverse effects, particularly gastrointestinal disturbances and signs of hypersensitivity.
* Monitor liver function tests if hepatic impairment is present or suspected.
* Monitor for signs of *C. difficile*-associated diarrhea.
### Clinical Pearls
* Administer 30-60 minutes before a meal to optimize pantoprazole absorption and efficacy.
* Ensure patients complete the full course of therapy to maximize eradication rates and minimize resistance development.
* Advise patients to report any signs of severe allergic reactions, severe diarrhea, or jaundice immediately.
* Consider potential for cross-reactivity with other beta-lactam antibiotics in patients with penicillin allergy.
***
**Disclaimer:** This information is intended for clinical use and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant clinical guidelines before making treatment decisions.